Quick Answer
Coherus Oncology, Inc. reported Shares Outstanding of 121.15 million shares for fiscal year 2025.
Coherus Oncology, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 121.15M | +4.8% |
| 2024 | 115.61M | +3.0% |
| 2023 | 112.22M | +42.3% |
| 2022 | 78.85M | +2.5% |
| 2021 | 76.93M | +6.1% |
| 2020 | 72.51M | +3.1% |
| 2019 | 70.37M | +3.0% |
| 2018 | 68.30M | +14.1% |
| 2017 | 59.84M | +30.6% |
| 2016 | 45.81M | +17.4% |
| 2015 | 39.01M | +17.3% |
| 2014 | 33.26M | +587.5% |
| 2013 | 4.84M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 116.24M | +0.9% | +0.0% |
| June 30, 2025 | 116.22M | +0.9% | +0.3% |
| March 31, 2025 | 115.91M | +2.1% | +0.3% |
| December 31, 2024 | 115.61M | +3.0% | +0.3% |
| September 30, 2024 | 115.21M | +5.6% | +0.0% |
| June 30, 2024 | 115.20M | +22.0% | +1.5% |
| March 31, 2024 | 113.50M | +41.0% | +1.1% |
| December 31, 2023 | 112.22M | +42.3% | +2.8% |
- Coherus Oncology, Inc. showed an increase of +4.8% in Shares Outstanding compared to the prior fiscal year.
- Over the 2013–2025 period, Coherus Oncology, Inc.’s shares outstanding has grown by 2404.4% (from 4.84 million shares to 121.15 million shares).
- The most recent figure is from Coherus Oncology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: